Merck Life Science/BioReliance End-to-End Solutions

5:15 PM - 5:30 PM (JST), Tuesday, March 5, 2019 ・ 2nd Floor
Merck is a leading science and technology company in healthcare, life science and performance materials.
BioReliance® End-to-End Solutions (Within Merck Life Science) encompass service and support for both emerging biotech and major biopharmaceutical companies that seek to accelerate process development, clinical drug production, and conceptual facilities design. As a trusted partner, we facilitate success by enabling our clients at any step from early-stage Process Development through commercial Facilities Design - anywhere in the world - having flexible solutions that optimize performance and providing guidance based upon first-hand experience. We operate our own in-house bioproduction facilities and convey our expertise to clients as they progress on their drug development journey, with an emphasis on Single-Use technologies and high-performance upstream and downstream systems.
Ticker:
MRK
Exchange:
Frankfurt (Germany)
Company Type:
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
China
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
CDMO and Facility Solutions
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided